Gotham Green Partners
VC Fund
Santa Monica, United States
Gotham Green Partners is a New York-based private equity firm focused on deploying capital into cannabis and cannabis-related enterprises on a global scale. The firm manages a diversified portfolio of investments and is actively investing across the cannabis value chain.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 63%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Gotham Green Partners invests in
Stages Gotham Green Partners invests in
Countries Gotham Green Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $6M–$25M
- Series B
- $10M–$125M
- Post-IPO Equity
- $3.5M–$50M
Investment Focus
Industry
- Cannabis 10 (33%)
- Retail 4 (13%)
- E-Commerce 3 (10%)
- Agriculture 3 (10%)
- Medical 2 (7%)
Stage
- Series A 7 (23%)
- Series B 4 (13%)
- Post-IPO Equity 4 (13%)
- Funding Round 3 (10%)
- Series C 2 (7%)
Country
- United States 15 (50%)
- Canada 3 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jason Adler
Managing Partner and Co-Founder
|
Managing Partner and Co-Founder | Total investments: 14 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lucid Green
|
Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $1.4M / Series C / Jul 10, 2024 | |
Trait Biosciences
|
Trait Biosciences is a cannabis biotechnology company harnessing research scientists in biotechnology and cannabis R&D to change the face of the industry. The company was founded in 2017 and is based in Vancouver, Canada. | Venture - Series Unknown / Oct 11, 2023 | |
Engin Sciences
|
Engin Sciences develops AI-Driven HR software that plugs into existing job boards, giving companies access to a virtual talent management system for hourly jobs, allowing HR managers to gamify the job application process on any site, quickly evaluating applicants, engaging and routing viable candidates to the jobs to which they’re best suited.Saving time and reducing churn, Engin saves companies thousands of dollars in HR personnel expenses. | $2.5M / Seed / Apr 06, 2023 | |
iAnthus
|
iAnthus provides financial operations to manage the cannabis industry. They focus on providing insights and solutions to cultivate and produce cannabis-based products for medical purposes. | $14M / Post-IPO Debt / Feb 02, 2023 | |
|
Lucid Green
|
Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $10M / Series B / Mar 27, 2022 | |
PreAct Technologies
|
PreAct Technologies aims to bridge the gap between collision avoidance systems and active safety technology. Every millisecond matters before a crash, and our patent-pending suite of sensor technologies, computing systems, and unique countermeasure algorithms aim to drastically reduce fatalities and injuries in a crash. Their Portland-based firmleverages existing vehicle infrastructure to predict and prepare both a vehicle and its occupants for an imminent collision. This alone can reduce the majority of injuries from the most common types of crashes while saving the industry billions of dollars annually.Seasoned automotive experts lead PreAct Technologies, with the engineering team comprised of leaders in computer vision, optics, and parallel processing. It arose from more than 15 years of DARPA-funded research in high-speed optics and computing systems and a major investment from Artis Corporation, the leading US provider of military active protection systems. | $13M / Nov 16, 2021 | |
|
PreAct Technologies
|
PreAct Technologies aims to bridge the gap between collision avoidance systems and active safety technology. Every millisecond matters before a crash, and our patent-pending suite of sensor technologies, computing systems, and unique countermeasure algorithms aim to drastically reduce fatalities and injuries in a crash. Their Portland-based firmleverages existing vehicle infrastructure to predict and prepare both a vehicle and its occupants for an imminent collision. This alone can reduce the majority of injuries from the most common types of crashes while saving the industry billions of dollars annually.Seasoned automotive experts lead PreAct Technologies, with the engineering team comprised of leaders in computer vision, optics, and parallel processing. It arose from more than 15 years of DARPA-funded research in high-speed optics and computing systems and a major investment from Artis Corporation, the leading US provider of military active protection systems. | $13M / Series A / Nov 16, 2021 | |
Jane Technologies
|
Jane Technologies is a cannabis retail tech company that provides its consumers with a confident, safe and simple shopping experience. Users can browse local products in real-time, compare by price, proximity or popularity and place orders at local stores for free. Jane partners with dispensaries on a win-win basis; stores only pay for completedorders at a fraction of the price of other industry software. | $100M / Series C / Aug 25, 2021 | |
Pebble Labs, Inc.
|
Pebble Labs is creating safe and effective biological solutions to sustainably protect yields and quality in food production. The company harnesses naturally occurring microbes from crops to deliver the power of RNA for solutions that target formidable pests and diseases. | $18.7M / Series A / Jul 26, 2021 | |
|
Trait Biosciences
|
Trait Biosciences is a cannabis biotechnology company harnessing research scientists in biotechnology and cannabis R&D to change the face of the industry. The company was founded in 2017 and is based in Vancouver, Canada. | $24.8M / Series A / Mar 22, 2021 | |
| See all 30 investments → | |||
Co-Investors
Btomorrow Ventures
3 deals together
Salveo Capital
3 deals together
Delta Emerald Ventures
2 deals together
Elev8.VC
2 deals together
Granite Hall Partners
2 deals together
Gron Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gotham Green Partners invest in?
Gotham Green Partners invests primarily in Cannabis, Retail and E-Commerce startups, most often at Series A and Series B stage. Most of the 30 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Gotham Green Partners's check size?
Gotham Green Partners typically joins rounds of $6M–$25M at Series A, $10M–$125M at Series B and $3.5M–$50M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gotham Green Partners participates in.
How do I contact Gotham Green Partners?
Public channels for Gotham Green Partners include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Gotham Green Partners?
The team at Gotham Green Partners includes Jason Adler (Managing Partner and Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
